 |
市場調査レポート
商品コード
1447883
造影剤の世界市場規模、シェア、成長分析、用途別、製品別、モダリティ別 - 産業予測、2024年～2031年Global Contrast Agents Market Size, Share, Growth Analysis, By Application(Hospitals, Clinics), By Product(Iodinated Contrast Media, Microbubble Contrast Media), By Modality(Ultrasound, X-ray/CT) - Industry Forecast 2024-2031 |
||||||
| 造影剤の世界市場規模、シェア、成長分析、用途別、製品別、モダリティ別 - 産業予測、2024年～2031年 |
|
出版日: 2024年02月29日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
造影剤の世界市場規模は2022年に52億2,000万米ドルと評価され、予測期間（2024年～2031年）のCAGRは2.71%で、2023年の53億6,000万米ドルから2031年には66億4,000万米ドルに成長する見通しです。
世界の造影剤市場は、着実な成長と技術の進歩を特徴とする、医療画像分野におけるダイナミックな分野です。造影剤は、画像診断の際に体内構造の視認性を高めるという極めて重要な役割を担っており、これにより様々な医療分野において正確な診断と治療計画の立案を容易にしています。最近の分析では、慢性疾患の増加、高齢化の進展、高度な診断技術に対する需要の高まりを主な要因として、市場は顕著な拡大を経験しています。さらに、副作用の少ない、より安全で効果的な造影剤の市場開拓など、造影剤製剤における絶え間ない技術革新が、市場の成長をさらに後押ししています。特に、市場情勢は進化する規制の枠組みやヘルスケア政策によっても形成され、製品承認、市場参入戦略、競合力学に影響を与えています。地域別に見ると、造影剤市場は一様ではない成長パターンを示しており、北米や欧州などの新興経済諸国は、強固なヘルスケアインフラ、高額な医療費、先進画像技術の早期導入などを背景に、大きな市場シェアを占めています。逆に、アジア太平洋やラテンアメリカの新興国は、ヘルスケアインフラの改善、可処分所得の増加、ヘルスケアへの投資の増加などに後押しされ、市場拡大の好機となっています。しかし、価格圧力、厳しい規制要件、代替画像モダリティの出現などの課題が市場参入者に大きな障害となっており、競争力を維持し成長を持続させるためには戦略的提携、製品の差別化、市場浸透戦略が必要となっています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- セカンダリおよびプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
造影剤の世界市場：用途別
- 市場概要
- 病院
- クリニック
造影剤の世界市場：製品別
- 市場概要
- ヨード造影剤
- マイクロバブル造影剤
造影剤の世界市場：モダリティ別
- 市場概要
- 超音波
- X線・CT
造影剤の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Bayer AG
- General Electric Company
- Guerbet
- Bracco Diagnostic, Inc.
- Nano Therapeutics Pvt. Ltd.
- Lantheus Medical Imaging, Inc.
- iMax
- Trivitron Healthcare
- GE Healthcare
- Hengrui Medicine
- YRPG
- BeiLu Pharma
- J.B. Chemicals and Pharmaceuticals Ltd.
- Unijules Life Sciences Ltd.
- SANOCHEMIA Pharmazeutika GmbH
- Taejoon Pharm
Global Contrast Agents Market size was valued at USD 5.22 billion in 2022 and is poised to grow from USD 5.36 billion in 2023 to USD 6.64 billion by 2031, growing at a CAGR of 2.71% in the forecast period (2024-2031).
The global contrast agents' market is a dynamic sector within the medical imaging field, characterized by steady growth and technological advancements. Contrast agents play a pivotal role in enhancing the visibility of internal body structures during diagnostic imaging procedures, thereby facilitating accurate diagnoses and treatment planning across various medical specialties. As of recent analysis, the market has experienced notable expansion, driven primarily by the increasing prevalence of chronic diseases, the growing aging population, and the rising demand for advanced diagnostic techniques. Moreover, the continual innovation in contrast agent formulations, such as the development of safer and more effective agents with minimal side effects, has further propelled market growth. Notably, the market landscape is also shaped by evolving regulatory frameworks and healthcare policies, influencing product approvals, market entry strategies, and competitive dynamics. Across geographical regions, the contrast agents market exhibits non-uniform growth patterns, with developed economies like North America and Europe holding substantial market shares attributed to their robust healthcare infrastructure, high healthcare expenditure, and early adoption of advanced imaging technologies. Conversely, emerging economies in Asia-Pacific and Latin America present lucrative opportunities for market expansion, fueled by improving healthcare infrastructures, rising disposable incomes, and increasing investments in healthcare. However, challenges such as pricing pressures, stringent regulatory requirements, and the emergence of alternative imaging modalities pose significant obstacles to market players, necessitating strategic collaborations, product differentiation, and market penetration strategies to maintain competitiveness and sustain growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contrast Agents Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Contrast Agents Market Segmental Analysis
The global contrast agents' market is segmented on the basis of application, product, modality and region. Based on application the market is segmented as, hospitals, clinics. Based on product the market is segmented as iodinated contrast media, microbubble contrast Media. Based on modality the market is segmented as ultrasound, X-ray/CT. Based on region the market is segmented as, North America, Europe, Asia-Pacific, MEA, and Latin America.
Drivers of the Global Contrast Agents Market
The global contrast agents market has experienced significant growth in recent years, driven by various factors such as technological advancements, increasing prevalence of chronic diseases, and rising demand for diagnostic imaging procedures. One notable driver of this market is the growing adoption of diagnostic imaging techniques across various medical fields, including radiology, cardiology, oncology, and neurology. Contrast agents play a crucial role in enhancing the visibility of internal body structures during imaging procedures such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound. With the continuous advancements in imaging technologies, there has been a greater emphasis on achieving higher resolution and improved diagnostic accuracy, thereby driving the demand for contrast agents.
Restraints in the Global Contrast Agents Market
However, despite the growth opportunities, the market also faces certain restraints, with one significant factor being the high cost associated with contrast agents and imaging procedures. The expense involved in acquiring imaging equipment, administering contrast agents, and interpreting imaging results can pose a financial burden on healthcare systems and patients alike. This cost factor may limit the accessibility of advanced imaging techniques, particularly in regions with limited healthcare infrastructure or economic constraints, thereby impeding market growth to some extent.
Market Trends of the Global Contrast Agents Market
On the other hand, a notable trend shaping the contrast agents' market is the increasing focus on the development of novel contrast agents with improved safety profiles and enhanced imaging properties. There is a growing demand for contrast agents that offer better tissue-specific targeting, reduced toxicity, and prolonged imaging enhancement, while also complying with stringent regulatory requirements. Manufacturers are investing in research and development activities to innovate new formulations, including nanoparticle-based agents, targeted contrast agents, and theranostic agents capable of both imaging and therapeutic functions. This trend underscores the ongoing efforts to address the evolving needs of healthcare professionals and patients, driving advancements in contrast agent technology and expanding the market's potential.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Contrast Agents Market by Application
- Market Overview
- Hospitals
- Clinics
Global Contrast Agents Market by Product
- Market Overview
- Iodinated Contrast Media
- Microbubble Contrast Media
Global Contrast Agents Market by Modality
- Market Overview
- Ultrasound
- X-ray/CT
Global Contrast Agents Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- General Electric Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Guerbet
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bracco Diagnostic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nano Therapeutics Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lantheus Medical Imaging, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- iMax
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Trivitron Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hengrui Medicine
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- YRPG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BeiLu Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- J.B. Chemicals and Pharmaceuticals Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Unijules Life Sciences Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SANOCHEMIA Pharmazeutika GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Taejoon Pharm
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
